Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
86.30
-4.50 (-4.96%)
At close: Mar 4, 2026
NSE:ARISTO Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 3, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2019 |
| Market Capitalization | 588 | 791 | 425 | 382 | - | - | Upgrade
|
| Market Cap Growth | -20.53% | 86.07% | 11.42% | - | - | - | Upgrade
|
| Enterprise Value | 913 | 986 | 661 | 662 | - | - | Upgrade
|
| Last Close Price | 86.30 | 115.72 | 61.96 | 55.44 | - | - | Upgrade
|
| PE Ratio | 15.98 | 19.47 | 10.91 | 10.71 | - | - | Upgrade
|
| PS Ratio | 0.16 | 0.25 | 0.17 | 0.18 | - | - | Upgrade
|
| PB Ratio | 1.42 | 2.12 | 1.26 | 1.26 | - | - | Upgrade
|
| P/TBV Ratio | 1.42 | 2.12 | 1.26 | 1.26 | - | - | Upgrade
|
| P/FCF Ratio | 13.32 | 16.11 | 40.66 | - | - | - | Upgrade
|
| P/OCF Ratio | 7.24 | 7.90 | 5.59 | - | - | - | Upgrade
|
| EV/Sales Ratio | 0.25 | 0.31 | 0.27 | 0.30 | - | - | Upgrade
|
| EV/EBITDA Ratio | 9.89 | 10.40 | 7.72 | 7.53 | - | - | Upgrade
|
| EV/EBIT Ratio | 14.15 | 14.33 | 9.46 | 9.12 | - | - | Upgrade
|
| EV/FCF Ratio | 20.71 | 20.09 | 63.25 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.84 | 0.59 | 0.62 | 0.75 | 1.71 | 1.66 | Upgrade
|
| Debt / EBITDA Ratio | 3.75 | 2.30 | 2.44 | 2.56 | 4.87 | 5.12 | Upgrade
|
| Debt / FCF Ratio | 7.86 | 4.45 | 19.97 | - | 7.22 | 75.47 | Upgrade
|
| Net Debt / Equity Ratio | 0.79 | 0.47 | 0.46 | 0.62 | 1.54 | 1.65 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.53 | 1.85 | 1.81 | 2.13 | 4.37 | 5.10 | Upgrade
|
| Net Debt / FCF Ratio | 7.39 | 3.58 | 14.79 | -2.73 | 6.48 | 75.09 | Upgrade
|
| Asset Turnover | 1.52 | 2.38 | 2.16 | 2.46 | 2.09 | 1.98 | Upgrade
|
| Inventory Turnover | 7.47 | 6.76 | 6.38 | 7.11 | 5.23 | 5.34 | Upgrade
|
| Quick Ratio | 0.78 | 0.63 | 0.75 | 0.85 | 0.70 | 0.59 | Upgrade
|
| Current Ratio | 1.12 | 1.21 | 1.26 | 1.39 | 1.23 | 1.24 | Upgrade
|
| Return on Equity (ROE) | 9.24% | 11.46% | 12.22% | 15.82% | 10.15% | 8.38% | Upgrade
|
| Return on Assets (ROA) | 1.70% | 3.21% | 3.85% | 5.13% | 3.26% | 2.66% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.48% | 9.84% | 10.29% | 12.60% | 8.17% | 7.70% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.00% | 15.30% | 16.00% | 18.00% | 15.90% | 14.10% | Upgrade
|
| Earnings Yield | 6.26% | 5.14% | 9.16% | 9.34% | - | - | Upgrade
|
| FCF Yield | 7.51% | 6.21% | 2.46% | -17.94% | - | - | Upgrade
|
| Dividend Yield | 0.58% | 0.43% | 0.65% | 0.45% | - | - | Upgrade
|
| Payout Ratio | 9.25% | 8.38% | 11.36% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.06% | - | -28.43% | -6.13% | - | - | Upgrade
|
| Total Shareholder Return | 0.52% | 0.43% | -27.78% | -5.67% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.